AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6487947
Drug: Small dose
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small dose of alcohol (0.44 ml.kg‐1)
Trial: 6487947
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose of alcohol (0.88 ml.kg‐1)
Trial: 6487947
Drug: Placebo (0.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.0 ml.kg‐1)
Trial: 26751765
Drug: Inactivated Enterovirus
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated Enterovirus 71 vaccine
Trial: 24929936
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (4 sessions of 1 hour per week for 2 weeks)
Trial: 24929936
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (1 session of 1 hour per week for 8 weeks)
Trial: 23585666
Drug: L-T3 (liothyronine)
RxNorm normalized name: L-T3
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-T3 (liothyronine)
Trial: 23585666
Drug: L-T4 (levothyroxine)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-T4 (levothyroxine)
Trial: 23585666
Drug: 5 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 μg TRH dose
Trial: 20937051
Drug: Furosemide IV
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide IV infusion + oral midodrine 15 mg administered 30 min before furosemide
Trial: 20937051
Drug: Furosemide IV
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide IV infusion + oral placebo administered 30 min before furosemide
Trial: 18384418
Drug: 0.5 microg
RxNorm normalized name: calcitriol 0.5 MICROGRAM In 1 CAPSULE ORAL CAPSULE, LIQUID FILLED [Rocaltrol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 microg kg(‐1) min(‐1) glyceryl trinitrate (GTN) infusion over 20 min
Trial: 12730416
Drug: +ISO (soy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: +ISO (soy protein with 83 mg isoflavones)
Trial: 16730418
Drug: ‐ISO (soy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ‐ISO (soy protein with 3 mg isoflavones)
Trial: 14680611
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA), 500 mg/day for 5 days
Trial: 14680611
Drug: Mifepristone (MIF),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone (MIF), 100 mg/day for 5 days
Trial: 14680611
Drug: Mifepristone (MIF)
DrugBank: Mifepristone (DB00834)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mifepristone (MIF) + Medroxyprogesterone acetate (MPA), 100 mg/day + 500 mg/day for 5 days
Trial: 2428269
Drug: 6% hydroxyethyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% hydroxyethyl starch (10 ml/kg body weight)
Trial: 2428269
Drug: 5.5% oxypolygelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.5% oxypolygelatin (10 ml/kg body weight)
Trial: 2428269
Drug: 5.0% human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0% human albumin (10 ml/kg body weight)
Trial: 24629060
Drug: ISDN (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISDN (10 mg/ml, 1%)
Trial: 20579405
Drug: Low-fat dairy
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat dairy consumption (500 ml low-fat milk and 150 g low-fat yogurt)
Trial: 20579405
Drug: Carbohydrate-rich control
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-rich control products (600 ml fruit juice and three fruit biscuits)
Trial: 16182039
Drug: 3-month oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month oral controlled diet followed by 3-month spontaneous dietary intake
Trial: 11205423
Drug: Nasal Spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal Spray
Trial: 7904330
Drug: Micronized progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized progesterone (1,200 mg)
Trial: 7904330
Drug: High levels
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High levels of allopregnanolone and pregnanolone (> or = 95.55 nmol/l)
Trial: 3030904
Drug: Bran biscuits
RxNorm normalized name: bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bran biscuits (12 biscuits, 1 = 1.3 g fibre)
Trial: 3030904
Drug: Placebo biscuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo biscuits (12 biscuits, 1 = 0.23 g fibre)
Trial: 21142812
Drug: Losartan/HCTZ (50mg/12.5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan/HCTZ (50mg/12.5mg daily)
Trial: 12953850
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (perindopril plus indapamide)
Trial: 3039882
Drug: Acyclovir, 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir, 5 mg/kg intravenously every 8 hours
Trial: 25372219
Drug: Low intensity
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low intensity laser therapy (LILT) - 790 nm, 30 mW continuous wave, 0.13 cm2 focal spot, applied energy of 3.6 J, fluence of 27.69 J/cm2
Trial: 19863517
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg PTX‐SR (Apo‐Pentoxifylline, Apotex Inc.) twice daily for 6 months
Trial: 6849741
Drug: Indoramin 25
RxNorm normalized name: indoramin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indoramin 25 mg
Trial: 8067273
Drug: Bright light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright light therapy (mean 4106 lx)
Trial: 8067273
Drug: Dim light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dim light therapy (mean 96 lx)
Trial: 3197677
Drug: Neurotol slow
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurotol slow (slow-release carbamazepine), administered twice daily
Trial: 3197677
Drug: Tegretol (conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegretol (conventional carbamazepine), administered three times daily
Trial: 29574518
Drug: Minodronate (MIN)
RxNorm normalized name: Minodronic acid
DrugBank: Minodronic acid (DB06548)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Minodronate (MIN) 50 mg once-monthly
Trial: 29574518
Drug: Risedronate (RIS)
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Risedronate (RIS) 75 mg once-monthly
Trial: 14623651
Drug: Intravenous contrast-enhanced
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous contrast-enhanced indirect magnetic resonance arthrography
Trial: 6605082
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment and Surgical treatment
Trial: 26964825
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy (NPWT) at 125 mm Hg
Trial: 26964825
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy (NPWT) at 75 mm Hg
Trial: 26964825
Drug: Traditional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional treatment (leaving wounds open)
Trial: 23958073
Drug: Cohen Flex-Tip
RxNorm normalized name: Ed Flex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cohen Flex-Tip blocker
Trial: 21250566
Drug: CPP-ACP containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPP-ACP containing cream applied for 3 minutes once per day during a 3-week treatment period
Trial: 21250566
Drug: Standard fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard fluoride toothpaste (1450 ppm F- as NaF) and abstaining from other oral hygiene products
Trial: 15781506
Drug: Propofol and
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol and remifentanil (bolus doses of propofol 3-5 mg/kg and remifentanil 1-4 microg/kg)
Trial: 15781506
Drug: Propofol with
RxNorm normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol with sevoflurane and nitrous oxide (propofol 3-5 mg/kg with 2%-8% sevoflurane and 70% nitrous oxide)
Trial: 15175435
Drug: IFL plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFL plus bevacizumab (5 mg/kg every two weeks)
Trial: 9305487
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg four times daily
Trial: 7697690
Drug: Omeprazole (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (both doses)
Trial: 3538987
Drug: sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual buprenorphine 200 mcg
Trial: 3538987
Drug: sublingual buprenorphine
RxNorm normalized name: buprenorphine Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual buprenorphine 400 mcg
Trial: 29471124
Drug: Daily vitamin
RxNorm normalized name: Daily Vitamin Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily vitamin D3 supplementation (400, 4000, or 10,000 IU)
Trial: 23147684
Drug: Computer-based clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-based clinical decision support with twice-monthly audits and printed management suggestions based on guideline-recommended blood pressure targets
Trial: 2082484
Drug: Aspirin, 50
RxNorm normalized name: Aspirin, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin, 50 mg t.i.d.
Trial: 2082484
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus dipyridamole, 50 mg t.i.d. plus 75 mg t.i.d.
Trial: 24959618
Drug: Sufentanil administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil administration at 0.15 ng · mL(‐1) until extubation
Trial: 24959618
Drug: Sufentanil administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil administration
Trial: 24959618
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline administration (Control group)
Trial: 22851805
Drug: SB‐649868 (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB‐649868 (10, 30, 60 mg)
Trial: 22851805
Drug: SB‐649868 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB‐649868 (60 mg)
Trial: 20170699
Drug: Risperidone 6mg
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone 6mg daily
Trial: 20170699
Drug: Olanzapine 20mg
RxNorm normalized name: OLANZAPINE 20MG TAB
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine 20mg daily
Trial: 18945282
Drug: Alcohol-based oily
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol-based oily disinfectant gel containing 70% ethanol after regular hand washing
Trial: 15832830
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy (ART) with 100% adherence
Trial: 15832830
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy (ART) with at least 80% adherence
Trial: 15832830
Drug: Antiretroviral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiretroviral therapy (ART) with < 80% adherence
Trial: 12875727
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg CEE + 2 mg MPA + 1 tab Caltrate‐D per day (Group A)
Trial: 12875727
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg CEE + 2 mg MPA + 1 tab Caltrate‐D per day (Group B)
Trial: 10606110
Drug: Intravenous enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous enoxaparin (1 mg/kg bolus dose)
Trial: 2145212
Drug: Vaccine with
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine with gamma-interferon (2 million units/m2)
Trial: 6380897
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (100 mg suppositories)
Trial: 6380897
Drug: Indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100 mg suppositories)
Trial: 30864768
Drug: ECA-Q (Embodied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECA-Q (Embodied Conversational Agent for smoking cessation), 14-day program delivered through Tablet computers
Trial: 25345257
Drug: 1% hydrocortisone
RxNorm normalized name: HYDROCORTISONE 0.01 g in 1 g TOPICAL OINTMENT [AFASSCO 1% Hydrocortisone]
DrugBank: Hydrocortisone (DB00741)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 1% hydrocortisone cream (HC)
Trial: 20356485
Drug: PCM group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCM group (pantoprazole 40 mg twice a day, clarithromycin 500 mg twice a day, metronidazole 400 mg twice a day for 7 days)
Trial: 7841054
Drug: rIFN‐alpha 2c
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIFN‐alpha 2c monotherapy (30 micrograms m‐2 s.c. twice weekly)
Trial: 7841054
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rIFN‐alpha 2c and rIFN‐gamma (30 micrograms m‐2 rIFN‐alpha 2c and 100 micrograms m‐2 rIFN‐gamma)
Trial: 2221590
Drug: Budesonide, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide, 400 micrograms daily for 1 yr
Trial: 515535
Drug: 0.02 mg
RxNorm normalized name: escin 0.02 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.02 mg of Ba 253 as metered aerosols
Trial: 515535
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg of Ba 253 as metered aerosols
Trial: 28082335
Drug: Theophylline (3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (3.75 mg/Kg)
Trial: 25474535
Drug: Acetaminophen 1
RxNorm normalized name: acetaminophen 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 1 g every 6 hours for 3 days
Trial: 24499497
Drug: NRL001 (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NRL001 (5, 7.5 or 10 mg)
Trial: 21577364
Drug: Lamotrigine (500.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (500.0 mg/d)
Trial: 21577364
Drug: Topiramate (300.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (300.0 mg/d)
Trial: 15610836
Drug: Midazolam 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.3 mg/kg/hr
Trial: 15610836
Drug: Midazolam 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.6 mg/kg/hr
Trial: 15610836
Drug: Midazolam 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.9 mg/kg/hr
Trial: 15610836
Drug: Midazolam 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 1.2 mg/kg/hr
Trial: 10746845
Drug: Estradiol vaginal
RxNorm normalized name: Estradiol Vaginal
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol vaginal tablets (EVT)
Trial: 3092610
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg glyceryl trinitrate (GTN) transdermal patches for 6 hours during exercise
Trial: 3092610
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg glyceryl trinitrate (GTN) transdermal patches for 6 hours during sauna
Trial: 23613481
Drug: Treatment‐As‐Usual (TAU)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment‐As‐Usual (TAU)
Trial: 21216318
Drug: Mandatory seasonal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandatory seasonal influenza vaccine program
Trial: 18305062
Drug: alemtuzumab, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alemtuzumab, 30 mg i.v. over 2 hours three times per week on alternate days for a maximum of 12 weeks
Trial: 18305062
Drug: chlorambucil, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: chlorambucil, 40 mg/m(2) orally every 28 days for a maximum of 12 months
Trial: 12547477
Drug: Mirtazapine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (up to 45 mg/day)
Trial: 10711525
Drug: Generic warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic warfarin sodium product (Barr Laboratories)
Trial: 8992905
Drug: Oral intubation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral intubation, suxamethonium (1.5 mg/kg)
Trial: 8992905
Drug: Oral intubation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral intubation, vecuronium (0.1 mg/kg)
Trial: 8992905
Drug: Nasal intubation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal intubation, suxamethonium (1.5 mg/kg)
Trial: 8992905
Drug: Nasal intubation,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal intubation, vecuronium (0.1 mg/kg)
Trial: 26339899
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 mg) with psychosocial support
Trial: 25168524
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation of the posterior tibialis nerve (treatment group, n = 12)
Trial: 17083352
Drug: 40 micro
RxNorm normalized name: Travoprost 40 microgram/mL eye drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 micro g ciclesonide
Trial: 17083352
Drug: 80 micro
RxNorm normalized name: Folic acid 80 microgram/mL oral solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 micro g ciclesonide
Trial: 10999558
Drug: Ganaxolone (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganaxolone (1500 mg/d on day 1 and 1875 mg/d on days 2 to 8, administered three times per day)
Trial: 7938556
Drug: Selective MAOI-A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective MAOI-A inhibitors (moclobemide, brofaromine)
Trial: 3130175
Drug: Adjuvant endocrine
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant endocrine therapy (TAM 20 mg/day orally for 2 years in postmenopausal patients; oophorectomy before TAM in premenopausal patients)
Trial: 3130175
Drug: Chemotherapy (0.06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (0.06 mg/kg of mitomycin C IV and 100 mg cyclophosphamide orally for 6 months repeated four times in 2 years)
Trial: 3130175
Drug: Chemoendocrine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoendocrine therapy (TAM with MMC + CPA chemotherapy)
Trial: 3130175
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy (TAM)
Trial: 9694611
Drug: Chemotherapy (MMC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (MMC + CPA)
Trial: 3130175
Drug: Chemoendocrine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoendocrine therapy (MMC + CPA + TAM)
Trial: 26819359
Drug: Intravenous pamidronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pamidronate (n = 11; total cumulative dose of 180 mg)
Trial: 23339047
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy (hyperinsulinaemic normoglycaemic clamp protocol)
Trial: 23339047
Drug: Control (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (standard therapy with no additional dietary supplement)
Trial: 17277349
Drug: Intensive statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive statin therapy (atorvastatin 80 mg/day, simvastatin 80 mg/day, or rosuvastatin 20-40 mg/day)
Trial: 14560320
Drug: Oral THC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral THC (0, 10 mg) administered five times/day during marijuana abstinence (days 9-14)
Trial: 14560320
Drug: Divalproex (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Divalproex (0, 1500 mg/day) maintained for 29 days
Trial: 11296186
Drug: Intermittent dobutamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent dobutamine infusion (IDI), 10 micromin, as needed (mean, once every 16 days, lasting for 12 to 48 h)
Trial: 11296186
Drug: Oral amiodarone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amiodarone, 400 mg/d, and IDI, 10 microg/kg/min, for 8 h every 7 days
Trial: 31514564
Drug: Mirror therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirror therapy combined with power and strength exercises
Trial: 24330810
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for chronic dizziness